Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: M&A comments over the years

M&A comments over the years

posted on Jan 29, 2008 09:47AM

To a true long these comments are becoming really tiring....

Today- 

2008 finds us in a better position to build a dynamic and exciting future for Patriot and it is our intent to do that. Our M&A search activity is being expanded by our having initiated efforts to engage an investment banking firm to help introduce us to candidate companies. We have already looked at a number of companies and are cautiously evaluating financial information. The range of companies we have looked at and will continue to focus on includes some in various areas of technology, early-stage investment, companies with established business operations, and interesting business units that offer opportunity for growth and profitability.  

11/2/07 

Speaking of potential, I've said many times that Patriot is actively seeking to develop a second revenue stream. I want that business to be predictable, product-based, and profitable. Well, we're making good progress on that front. Throughout the summer months I've been meeting with several high-tech companies and, with our CFO and members of the board of directors, we've evaluated more than 30 different companies in different industries from small 3-person startups to established firms with over 100 employees. A few of the meetings were brief; others progressed quite well and we've started a second phase of deeper discussions with some of the better candidates. We're being very thorough in our evaluation, involving each of our board members in turn and tapping outside advisors when that's appropriate. Overall I'm very excited about the prospects for expanding Patriot and broadening our opportunities. I'll be sure to share progress reports as we move along.

10/11/07 

Turley reconfirmed that Patriot Scientific is continuing to actively evaluate sources and opportunities to create additional recurring revenue through possible joint ventures or acquisitions, all with the goal of increasing shareholder value.

9/5/07 

Regarding our cash, I met recently with the board of directors and we decided not to pay out a dividend this period. We’ll revisit this issue regularly but for now I think we can put that cash to much better use in growing the company, as I hope to show you later this year. 

5/15/07 

Pohl's comments also covered the topic of activities related to possible mergers and acquisitions or joint ventures. A merger or acquisition transaction with another company might be one way to accomplish getting listed on a national exchange. Discussions in October and November of 2006 with a privately held company that was a merger candidate broke down over the issue of valuation. There are informal indications the other company may want to rekindle discussions. 

5/3/07 

"As evidenced by information in our recent quarterly report and presented at our annual meeting of shareholders last week, we are continuing to seek and evaluate opportunities to diversify our revenue stream by developing and marketing new technologies, entering into joint ventures or by acquiring other companies and technologies," Pohl stated. "We are always focused on the goal of increasing the financial position and strength of the company and providing value to our shareholders."  

4/24/07 

Pohl reconfirmed that Patriot Scientific is continuing to actively evaluate sources and opportunities to create additional recurring revenue through possible joint ventures or acquisitions, all with the goal of increasing shareholder value. 

4/11/07 

"We will continue to seek and evaluate opportunities to diversify our revenue stream by developing and marketing new technologies, entering into joint ventures or by acquiring other companies and technologies," Pohl stated, "always pointed toward the goal of increasing the financial position and strength of the company and providing value to our shareholders."  

2/23/07 

Beginning in October, 2006, we began and continued preliminary discussions toward possible acquisition of two different companies. We consulted a prominent investment banking firm when taking a preliminary look at a company that is on the verge of developing a revenue stream. The company on which we were focusing is beginning to market promising technology protected by an impressive patent portfolio in their market niche. We amicably ended discussions with the target company in late December. 
 

2/22/07 

"We have already embarked upon our plan for the future of Patriot Scientific by seeking and evaluating opportunities to add to and diversify our revenue stream by acquiring other companies and technologies, entering into joint ventures, developing and marketing new proprietary products or technologies, or a combination of any of those alternatives,"  

2/20/07 

"We have already embarked upon our plan for the future of Patriot Scientific by seeking and evaluating opportunities to add to and diversify our revenue stream by acquiring other companies and technologies, entering into joint ventures, developing and marketing new proprietary products or technologies, or a combination of any of those alternatives," said Pohl.   

2/8/07 

"We will continue to seek and evaluate opportunities to diversify our revenue stream by developing and marketing new technologies, entering into joint ventures or by acquiring other companies and technologies," Pohl stated, "always pointed toward the goal of increasing the financial position and strength of the company and providing value to our shareholders." 
  

1/18/07 

Pohl also noted that Patriot Scientific is continuing to actively evaluate sources and opportunities to create additional recurring revenue through possible joint ventures or acquisitions, all with the goal of increasing shareholder value. 

12/11/06

"Increased value for Patriot Scientific shareholders is our fundamental driver," Pohl continued. "While the very busy Alliacense team negotiates with more and more global manufacturers to become licensees of our jointly owned patent portfolio, the Patriot management and board are pursuing the other prong of our two-fold strategy by engaging in ongoing negotiations for a potential joint venture to enhance our Ignite(TM) chip as well as engaging in communications with another technology company whose attractive potential may lead to an investment or acquisition by Patriot." 

11/27/06

"Pohl noted that preliminary discussions are currently being held with several companies that are candidates for Patriot Scientific to possibly either acquire the companies or their technologies, or to enter into joint ventures related to existing or new technologies." 

10/23/06

"Pohl also noted that Patriot Scientific is actively evaluating sources and opportunities to create additional recurring revenue through possible joint ventures or acquisitions, all with the goal of increasing shareholder value."
 

9/20/06

"Consistent with our business plan, we are also evaluating potential acquisition opportunities that would provide value and an additional revenue stream. The mention of these alternative uses of cash does not preclude us from declaring future cash dividends to shareholders. Lastly, we continue to work toward the goal of getting Patriot listed and traded on a national exchange such as the NASDAQ, AMEX or NYSE."

Share
New Message
Please login to post a reply